LIXTE Biotechnology Provides Update On Recent Activities and Developments
Provided By GlobeNewswire
Last update: Aug 19, 2024
-Collaboration with NKI and Funding Support for New Colorectal Cancer Clinical Trial by Major Pharma Company-
-Distinguished Oncologist Jan Schellens Joins LIXTE as Chief Medical Officer-
Read more at globenewswire.comNASDAQ:LIXTW (7/18/2025, 8:00:02 PM)
0.1767
+0.01 (+3.94%)
4.06
+0.28 (+7.41%)
Find more stocks in the Stock Screener
